Delivery Order SPE2DR25D2102-SPE2DR26FB2EW
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $14,080.56 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injector pens, with a completion date of November 17, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, PA. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $2,392.50 to AmerisourceBergen Drug Corp for REPATHA 140 MG/ML SureClick auto-injector pens, with an ultimate completion date of October 23, 2025. This is a firm fixed price delivery order with no set-aside designation, performed at the contractor's Conshohocken, Pennsylvania location. The award represents a single transaction under AmerisourceBergen's larger pharmaceutical supply vehicle with the DLA. This delivery order falls...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,618.92 to AmerisourceBergen Drug Corp for REPATHA 140 mg/mL SureClick auto-injector pens, with performance in Conshohocken, Pennsylvania and completion scheduled for September 22, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a pharmaceutical supply requirement under the federal medical procurement system supporting military and veteran healthcare needs....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,960.21 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injector pens, with an ultimate completion date of August 7, 2025. The contract employs firm fixed-price pricing and was awarded competitively without set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor on this order, which represents a single transaction under a larger DLA Troop...
- The Defense Logistics Agency awarded a $13,305.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors, with an ultimate completion date of October 31, 2025. This non-set-aside competitive award was issued on October 30, 2025, with performance to be executed at AmerisourceBergen's Conshohocken, Pennsylvania corporate office. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $12,614.03 to AmerisourceBergen Drug Corp for REPATHA 140 mg/mL SureClick auto-injector pens, with an ultimate completion date of November 7, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is one of the nation's largest pharmaceutical distributors and serves as a critical vendor for federal...
- The Defense Logistics Agency awarded a $5,181.96 delivery order to AmerisourceBergen Drug Corp for REPATHA 140 MG/ML SureClick auto-injector pharmaceuticals, with an ultimate completion date of October 16, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $3,696.37 firm fixed-price delivery order for Repatha 140 mg/ml SureClick auto-injector pens, with performance in Conshohocken, Pennsylvania and completion scheduled for November 12, 2025. This competitive award, issued on November 10, 2025, carries no set-aside designation and represents a child order under AmerisourceBergen's broader contract vehicle with DLA. This delivery order falls under AmerisourceBergen's substantial...
- The Defense Logistics Agency awarded a $80,596.93 delivery order contract to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injector pens. This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of September 29, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and...
- The Defense Logistics Agency awarded a delivery order valued at $2,254.40 to AmerisourceBergen Drug Corp for the supply of REPATHA 140 mg/ml SureClick auto-injectors. The contract, awarded on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a firm fixed price delivery order with no set-aside designation. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains its corporate headquarters and serves as a...
- SPE2DR25D2102Indefinite Delivery Contract
- SPE2DR25D2102-SPE2DR26FB2EWDelivery Order
The Defense Logistics Agency awarded a $11,577.15 firm fixed price delivery order to AmerisourceBergen Drug Corp for REPATHA 140 MG/ML SureClick auto-injector pens. The award, issued on November 14, 2025, with an ultimate completion date of November 17, 2025, represents a competitive procurement with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables comprehensive global pharmaceutical support across multiple therapeutic domains for Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. REPATHA is a cardiovascular medication used to lower cholesterol levels, reflecting the breadth of specialty pharmaceutical products supplied by AmerisourceBergen to support military medical readiness and healthcare delivery.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.6k | 11/14/25 |